Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A class of therapeutic strategies or compounds that exert anti-inflammatory effects by modulating several molecular and cellular pathways, rather than acting on a single, well-defined receptor or protein. These strategies often target multiple interconnected signaling routes such as MAPKs, NF-kB/JAK-STAT axis, arachidonic acid metabolism enzymes like COXs/LOXs, nuclear hormone receptors like PPARs, and pattern recognition molecules such as TLRs. The precise molecular targets are often not fully characterized, especially in the case of natural products or multi-component drugs, making mechanistic elucidation challenging.
Varies depending on the specific targets modulated; includes inhibition of kinase activity, suppression of transcription factor activation, enzyme inhibition, modulation of receptor signaling, and alteration of cytokine production.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Targets Including Anti-Inflammatory Pathways.